AstraZeneca Plc raised its annual forecast, driven by strong demand for its blockbuster cancer drugs, and revealed a plan to ...

J&J filed a lawsuit Tuesday in the US District Court for the District of Columbia alleging the US Health Resources and ...

In 2025, if the plan has a deductible, the $35 will not count towards that amount, but it will count towards the $2,000 ...

Building upon a successful end-of-Phase 2 meeting, received FDA "Study ... and business fronts,” said Stephen Brady, ...

The president-elect has said he’ll let Robert F. Kennedy Jr. “go wild” on healthcare, while many expect a leadership change ...

A bumper crop of revisions, including a stronger drug benefit, means the Medicare plan you enrolled in for 2024 may not be ...

Responding to Law Enforcement and Safeguarding Your Interests - In this final installment of our series on government ...

Catheter Precision, Inc. (NYSE American:VTAK), a U.S.-based innovative medical device company focused on electrophysiology products, today announced its financial results and operational update for ...

DNA synthesis platform developer joins de novo designer in latest of three partnerships recently launched or advanced.

Nov 5 (Reuters) - The U.S. Food and Drug Administration on Tuesday extended ... Booking.com could cut jobs as part of reorganization plan 10:09 AM UTC Autos & Transportationcategory Exclusive ...

"I am thrilled to further strengthen and enrich Ocular's senior leadership team with the appointment of Namrata as Chief ...

“FDA’s war on public health is about to end ... “In my 50 years in the business, I never had to encounter, even in the first Trump administration, a callous disregard for science and ...